Authors:
Wells, P
Ginsberg, JS
Anderson, DR
Kearon, C
Gent, M
Weitz, J
Barnes, D
Hirsh, J
Citation: P. Wells et al., Utility of ultrasound imaging of the lower extremities in the diagnostic approach in patients with suspected pulmonary embolism, J INTERN M, 250(3), 2001, pp. 262-264
Citation: Sd. Chunilal et Js. Ginsberg, Advances in the diagnosis of venous thromboembolism - A multimodal approach, J THROMB TH, 12(1), 2001, pp. 53-57
Authors:
Crowther, MA
Roberts, J
Roberts, R
Johnston, M
Stevens, P
Skingley, P
Patrassi, GM
Sartori, MT
Hirsh, J
Prandoni, P
Weitz, JI
Gent, M
Ginsberg, JS
Citation: Ma. Crowther et al., Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study, THROMB HAEM, 85(3), 2001, pp. 390-394
Authors:
Bates, SM
Weitz, JI
Johnston, M
Hirsh, J
Ginsberg, JS
Citation: Sm. Bates et al., Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin, ARCH IN MED, 161(3), 2001, pp. 385-391
Authors:
Heit, JA
Colwell, CW
Francis, CW
Ginsberg, JS
Berkowitz, SD
Whipple, J
Peters, G
Citation: Ja. Heit et al., Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement - A phase 2 dose-finding study, ARCH IN MED, 161(18), 2001, pp. 2215-2221
Authors:
Ginsberg, JS
Hirsh, J
Julian, J
Vander LaandeVries, M
Magier, D
MacKinnon, B
Gent, M
Citation: Js. Ginsberg et al., Prevention and treatment of postphlebitic syndrome - Results of a 3-part study, ARCH IN MED, 161(17), 2001, pp. 2105-2109
Authors:
Kearon, C
Ginsberg, JS
Douketis, J
Crowther, M
Brill-Edwards, P
Weitz, JI
Hirsh, J
Citation: C. Kearon et al., Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing, ANN INT MED, 135(2), 2001, pp. 108-111
Authors:
Douketis, JD
Crowther, MA
Foster, GA
Ginsberg, JS
Citation: Jd. Douketis et al., Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?, AM J MED, 110(7), 2001, pp. 515-519
Authors:
Bates, SM
Ginsberg, JS
Straus, SE
Rekers, H
Sackett, DL
Citation: Sm. Bates et al., Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism, CAN MED A J, 163(8), 2000, pp. 1016-1021
Authors:
Wells, PS
Anderson, DR
Rodger, M
Ginsberg, JS
Kearon, C
Gent, M
Turpie, AGG
Bormanis, J
Weitz, J
Chamberlain, M
Bowie, D
Barnes, D
Hirsh, J
Citation: Ps. Wells et al., Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer, THROMB HAEM, 83(3), 2000, pp. 416-420
Citation: Sm. Bates et Js. Ginsberg, Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism, THROMB HAEM, 83(2), 2000, pp. 182-184
Authors:
Ray, JG
Burows, RF
Ginsberg, JS
Burrows, EA
Citation: Jg. Ray et al., Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: Review and recommendations for management of the pregnant and nonpregnant patient, HAEMOSTASIS, 30(3), 2000, pp. 103-117
Authors:
Eikelboom, JW
Anand, SS
Malmberg, K
Weitz, JI
Ginsberg, JS
Yusuf, S
Citation: Jw. Eikelboom et al., Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without St elevation: a meta-analysis, LANCET, 355(9219), 2000, pp. 1936-1942
Authors:
Douketis, JD
Gordon, M
Johnston, M
Julian, JA
Adachi, JR
Ginsberg, JS
Citation: Jd. Douketis et al., The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: Prospective cohortstudy and review of the literature, THROMB RES, 99(1), 2000, pp. 25-34
Authors:
Kearon, C
Harrison, L
Crowther, M
Ginsberg, JS
Citation: C. Kearon et al., Optimal dosing of subcutaneous unfractionated heparin for the treatment ofdeep vein thrombosis, THROMB RES, 97(6), 2000, pp. 395-403
Citation: Sd. Chunilal et Js. Ginsberg, Strategies for the diagnosis of deep vein thrombosis and pulmonary embolism, THROMB RES, 97(1), 2000, pp. V33-V48
Authors:
Brill-Edwards, P
Ginsberg, JS
Gent, M
Hirsh, J
Burrows, R
Kearon, C
Geerts, W
Kovacs, M
Weitz, JI
Robinson, KS
Whittom, R
Couture, G
Citation: P. Brill-edwards et al., Safety of withholding heparin in pregnant women with a history of venous thromboembolism., N ENG J MED, 343(20), 2000, pp. 1439-1444
Authors:
Douketis, JD
Foster, GA
Crowther, MA
Prins, MH
Ginsberg, JS
Citation: Jd. Douketis et al., Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy, ARCH IN MED, 160(22), 2000, pp. 3431-3436
Authors:
Dolovich, LR
Ginsberg, JS
Douketis, JD
Holbrook, AM
Cheah, G
Citation: Lr. Dolovich et al., A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism - Examining some unanswered questions regarding location of treatment, product type, and dosing frequency, ARCH IN MED, 160(2), 2000, pp. 181-188